Lataa...
Randomized Controlled Trial of Subcutaneous Epoetin Alfa-epbx Versus Epoetin Alfa in End-Stage Kidney Disease
INTRODUCTION: This double-blind, randomized controlled trial compared the safety and efficacy of subcutaneous epoetin alfa-epbx, an epoetin alfa biosimilar, with the reference product, epoetin alfa, in hemodialysis patients with end-stage kidney disease (ESKD) and anemia who were receiving epoetin a...
Tallennettuna:
| Julkaisussa: | Kidney Int Rep |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6734106/ https://ncbi.nlm.nih.gov/pubmed/31517143 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2019.05.010 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|